Aggregatibacter actinomycetemcomitans biofilm killing by a targeted ciprofloxacin prodrug

References

• Hennard, C, Truong, QC, Desnottes, JF, Paris, JM, Moreau, NJ, Abdallah, MA 2001. Synthesis and activities of pyoverdin-quinolone adducts: a prospective approach to a specific therapy against Pseudomonas aeruginosa. J Med Chem. 44:2139–2151.
   Google Scholar
• Weber, RW, Boutin, RH, Nedelman, MA, Lister-James, J, Dean, RT 1990. Enhanced kidney clearance with an ester-linked Tc-99m-radiolabeled antibody Fab’-chelator conjugate. Bioconjug Chem. 1:431–437.
   Google Scholar
• Aframian DJ, Davidowitz T, Benoliel R. 2006. The distribution of oral mucosal pH values in healthy saliva secretors. Oral Dis. 12 : 420–423.
   PubMed Web of Science ®Google Scholar
• Conway TB, Beck FM, Walters JD. 2000. Gingival fluid ciprofloxacin levels at healthy and inflamed human periodontal sites. J Periodontol. 71 : 1448–1452.
   PubMed Web of Science ®Google Scholar
• Eckert R, He J, Yarbrough DK, Qi FX, Anderson MH, Shi WY. 2006. Targeted killing of Streptococcus mutans by a pheromone-guided ‘smart’ antimicrobial peptide. Antimicrob Agents Chemother. 50 : 3651–3657.
   PubMed Web of Science ®Google Scholar
• Fine DH, Markowitz K, Furgang D, Fairlie K, Ferrandiz J, Nasri C, McKiernan M, Gunsolley J. 2007. Aggregatibacter actinomycetemcomitans and its relationship to initiation of localized aggressive periodontitis: longitudinal cohort study of initially healthy adolescents. J Clin Microbiol. 45 : 3859–3869.
   PubMed Web of Science ®Google Scholar
• Garlet GP, Avila-Campos MJ, Milanezi CM, Ferreira BR, Silva JS. 2005. Actinobacillus actinomycetemcomitans-induced periodontal disease in mice: patterns of cytokine, chemokine, and chemokine receptor expression and leukocyte migration. Microbes Infect. 7 : 738–747.
   PubMed Web of Science ®Google Scholar
• Garlet GP, Cardoso CRB, Campanelli AP, Ferreira BR, Avila-Campos MJ, Cunha FQ, Silva JS. 2007. The dual role of p55 tumor necrosis factor-α receptor in Actinobacillus actinomycetemcomitans-induced experimental periodontitis: host protection and tissue destruction. Clin Exp Immunol. 147 : 128–138.
   PubMed Web of Science ®Google Scholar
• Gmür R, Thurnheer T. 1996. Monoclonal antibodies for the rapid identification in clinical samples of Peptostreptococcus micros and Actinobacillus actinomycetemcomitans serotypes a, d, and e. Med Microbiol Lett. 5 : 335–349.
   Web of Science ®Google Scholar
• Graves DT, Fine D, Teng YTA, Van Dyke TE, Hajishengallis G. 2008. The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J Clin Periodontol. 35 : 89–105.
   PubMed Web of Science ®Google Scholar
• Griffiths GS. 2003. Formation, collection and significance of gingival crevice fluid. Periodontol 2000. 31 : 32–42.
   PubMed Web of Science ®Google Scholar
• Harrison RG, Todd P, Rudge SR, Petrides DP. 2003. Bioseparations science and engineering. New York: Oxford University Press.
   Google Scholar
• Hennard C, Truong QC, Desnottes JF, Paris JM, Moreau NJ, Abdallah MA. 2001. Synthesis and activities of pyoverdin-quinolone adducts: a prospective approach to a specific therapy against Pseudomonas aeruginosa. J Med Chem. 44 : 2139–2151.
   PubMed Web of Science ®Google Scholar
• Hoogkamp-Korstanje JAA, Roelofs-Willemse J. 2000. Comparative in vitro activity of moxifloxacin against Gram-positive clinical isolates. J Antimicrob Chemother. 45 : 31–39.
   PubMed Web of Science ®Google Scholar
• Kaplan CW, Sim JH, Shah KR, Kolesnikova-Kaplan A, Shi WY, Eckert R. 2011. Selective membrane disruption: mode of action of C16G2, a specifically targeted antimicrobial peptide. Antimicrob Agents Chemother. 55 : 3446–3452.
   PubMed Web of Science ®Google Scholar
• Kaplan JB, Ragunath C, Ramasubbu N, Fine DH. 2003. Detachment of Actinobacillus actinomycetemcomitans biofilm cells by an endogenous beta-hexosaminidase activity. J Bacteriol. 185 : 4693–4698.
   PubMed Web of Science ®Google Scholar
• Lemmon, EW, McLinden, MO, Friend, DG 2011. Thermophysical properties of fluid systems. In: Linstrom PJ, Mallard WC, editors. NIST chemistry webBook, NIST standard reference database number 69. Gaithersburg (MD): National Institute of Standards and Technology; [cited 2012 Nov 9]. Available from: http://www.webbook.nist.gov.
   Google Scholar
• Li Y, Messina C, Bendaoud M, Fine DH, Schreiner H, Tsiagbe VK. 2010. Adaptive immune response in osteoclastic bone resorption induced by orally administered Aggregatibacter actinomycetemcomitans in a rat model of periodontal disease. Mol Oral Microbiol. 25 : 275–292.
   PubMed Web of Science ®Google Scholar
• Liu C, Worthington RJ, Melander C, Wu H. 2011. A new small molecule specifically inhibits the cariogenic bacterium Streptococcus mutans in multispecies biofilms. Antimicrob Agents Chemother. 55 : 2679–2687.
   PubMed Web of Science ®Google Scholar
• Mai J, Tian XL, Gallant JW, Merkley N, Biswas Z, Syvitski R, Douglas SE, Ling JQ, Li YH. 2011. A novel target-specific, salt-resistant antimicrobial peptide against the cariogenic pathogen Streptococcus mutans. Antimicrob Agents Chemother. 55 : 5205–5213.
   PubMed Web of Science ®Google Scholar
• Muller HP, Holderrieth S, Burkhardt U, Hoffler U. 2002. In vitro antimicrobial susceptibility of oral strains of Actinobacillus actinomycetemcomitans to seven antibiotics. J Clin Periodontol. 29 : 736–742.
   PubMed Web of Science ®Google Scholar
• Noel S, Gasser V, Pesset B, Hoegy F, Rognan D, Schalk IJ, Mislin GLA. 2011. Synthesis and biological properties of conjugates between fluoroquinolones and a N3″-functionalized pyochelin. Org Biomol Chem. 9 : 8288–8300.
   PubMed Web of Science ®Google Scholar
• Periasamy S, Kolenbrander PE. 2009. Aggregatibacter actinomycetemcomitans builds mutualistic biofilm communities with Fusobacterium nucleatum and Veillonella species in saliva. Infect Immun. 77 : 3542–3551.
   PubMed Web of Science ®Google Scholar
• Preetha A, Banerjee R. 2005. Comparison of artificial saliva substitutes. Trends Biomater Artif Organs. 18 : 178–186.
   Google Scholar
• Qiu XQ, Zhang H, Wang H, Wu GY. 2005. A novel engineered peptide, a narrow-spectrum antibiotic, is effective against vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother. 49 : 1184–1189.
   PubMed Web of Science ®Google Scholar
• Raj PA, Dentino AR. 2005. Intraoral delivery of antimicrobials. Drug News Perspect. 18 : 362–374.
   PubMed Web of Science ®Google Scholar
• Roberts FA, Darveau RP. 2002. Beneficial bacteria of the periodontium. Periodontol 2000. 30 : 40–50.
   PubMed Web of Science ®Google Scholar
• Schreiner HC, Sinatra K, Kaplan JB, Furgang D, Kachlany SC, Planet PJ, Perez BA, Figurski DH, Fine DH. 2003. Tight-adherence genes of Actinobacillus actinomycetemcomitans are required for virulence in a rat model. Proc Nat Acad Sci USA. 100 : 7295–7300.
   PubMed Web of Science ®Google Scholar
• Schwach-Abdellaoui K, Vivien-Castioni N, Gurny R. 2000. Local delivery of antimicrobial agents for the treatment of periodontal diseases. Eur J Pharm Biopharm. 50 : 83–99.
   PubMed Web of Science ®Google Scholar
• Smith JN, Wang J, Lin YH, Timchalk C. 2010. Pharmacokinetics of the chlorpyrifos metabolite 3,5,6-trichloro-2-pyridinol (TCPy) in rat saliva. Toxicol Sci. 113 : 315–325.
   PubMed Web of Science ®Google Scholar
• Southard GL, Godowski KC. 1998. Subgingival controlled release of antimicrobial agents in the treatment of periodontal disease. Int J Antimicrob Agents. 9 : 239–253.
   PubMed Web of Science ®Google Scholar
• Suci P, Kang S, Gmür R, Douglas T, Young M. 2010. Targeted delivery of a photosensitizer to Aggregatibacter actinomycetemcomitans biofilm. Antimicrob Agents Chemother. 54 : 2489–2496.
   PubMed Web of Science ®Google Scholar
• Suci P, Young M. 2011. Selective killing of Aggregatibacter actinomycetemcomitans by ciprofloxacin during development of a dual species biofilm with Streptococcus sanguinis. Arch Oral Biol. 56 : 1055–1063.
   PubMed Web of Science ®Google Scholar
• Thurnheer T, Gmür R, Shapiro S, Guggenheim B. 2003. Mass transport of macromolecules within an in vitro model of supragingival plaque. Appl Environ Microbiol. 69 : 1702–1709.
   PubMed Web of Science ®Google Scholar
• Tozum TF, Yildirim A, Caglayan F, Dincel A, Bozkurt A. 2004. Serum and gingival crevicular fluid levels of ciprofloxacin in patients with periodontitis. J Am Dent Assoc. 135 : 1728–1732.
   PubMed Web of Science ®Google Scholar
• Trombone APF, Ferreira SB, Raimundo FM, de Moura KCR, Avila-Campos MJ, Silva JS, Campanelli AP, De Franco M, Garlet GP. 2009. Experimental periodontitis in mice selected for maximal or minimal inflammatory reactions: increased inflammatory immune responsiveness drives increased alveolar bone loss without enhancing the control of periodontal infection. J Periodontal Res. 44 : 443–451.
   PubMed Web of Science ®Google Scholar
• Vrany JD, Stewart PS, Suci PA. 1997. Comparison of recalcitrance to ciprofloxacin and levofloxacin exhibited by Pseudomonas aeruginosa biofilms displaying rapid-transport characteristics. Antimicrob Agents Chemother. 41 : 1352–1358.
   PubMed Web of Science ®Google Scholar
• Walker C, Karpinia K. 2002. Rationale for use of antibiotics in periodontics. J Periodontol. 73 : 1188–1196.
   PubMed Web of Science ®Google Scholar
• Weber RW, Boutin RH, Nedelman MA, Lister-James J, Dean RT. 1990. Enhanced kidney clearance with an ester-linked Tc-99m-radiolabeled antibody fab’-chelator conjugate. Bioconjug Chem. 1 : 431–437.
   PubMed Web of Science ®Google Scholar